Molecular targets and cancer therapeutics

被引：0
|
作者：
Serfass, Lucile [1 ]
Van Herpen, Carla
Saghatchian, Mahasti
机构：
[1] EORTC, Brussels, Belgium
[2] Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen, Netherlands
[3] Inst Gustave Roussy, Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2007年 / 43卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1494 / 1495
页数：2
相关论文
共 50 条
  • [41] Metabolic targets for potential prostate cancer therapeutics
    Twum-Ampofo, Jeffrey
    Fu, De-Xue
    Passaniti, Antonino
    Hussain, Arif
    Siddiqui, M. Minhaj
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (03) : 241 - 247
  • [42] BET Proteins as Attractive Targets for Cancer Therapeutics
    Sarnik, Joanna
    Poplawski, Tomasz
    Tokarz, Paulina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (20)
  • [43] MicroRNAs as Targeted Therapeutics and Therapeutic Targets in Cancer
    Slack, Frank
    NUCLEIC ACID THERAPEUTICS, 2012, 22 (06) : A10 - A10
  • [44] Molecular Targets in Advanced Therapeutics of Cancers: The Role of Pharmacogenetics
    Abubakar, Murtala B.
    Gan, Siew Hua
    ONCOLOGY, 2016, 91 (01) : 3 - 12
  • [45] Molecular targets in cerebral ischemia for developing novel therapeutics
    Mehta, Suresh L.
    Manhas, Namratta
    Rahubir, Ram
    BRAIN RESEARCH REVIEWS, 2007, 54 (01) : 34 - 66
  • [46] Molecular therapeutics in pancreas cancer
    Narayanan, Vignesh
    Weekes, Colin D.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 8 (04) : 366 - 379
  • [47] Molecular therapeutics in pancreas cancer
    Vignesh Narayanan
    Colin D Weekes
    World Journal of Gastrointestinal Oncology, 2016, (04) : 366 - 379
  • [48] Molecular therapeutics in prostate cancer
    Nicholson, B
    Theodorescu, D
    HISTOLOGY AND HISTOPATHOLOGY, 2003, 18 (01) : 275 - 298
  • [49] MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics
    Xia, H.
    Hui, K. M.
    CANCER GENE THERAPY, 2012, 19 (11) : 723 - 730
  • [50] Protein hydroxylations as molecular targets for cancer therapeutics: Deferiprone is a candidate for probing multitargeted inhibition.
    Hanauske-Abel, HM
    Slowinska, B
    McCaffrey, TM
    Cracchiolo, BM
    Hanauske, AR
    CLINICAL CANCER RESEARCH, 1999, 5 : 3767S - 3767S
12345